Skip to content
Clinical Research Made Simple

Clinical Research Made Simple

Trusted Resource for Clinical Trials, Protocols & Progress

Tag: monitoring investigator responsibilities

Investigator Responsibilities in Clinical Trials: GCP Compliance and Best Practices

Posted on May 14, 2025 digi By digi

Investigator Responsibilities in Clinical Trials: GCP Compliance and Best Practices Mastering Investigator Responsibilities for Ethical and Compliant Clinical Trials Investigators are central figures in clinical research, entrusted with protecting participant rights, ensuring protocol adherence, and maintaining data integrity. Their leadership and commitment to Good Clinical Practice (GCP) are vital to the ethical, scientific, and regulatory…

Read More “Investigator Responsibilities in Clinical Trials: GCP Compliance and Best Practices” »

Good Clinical Practice (GCP) and Compliance, Investigator Responsibilities

Quick Guide

  • Clinical Trial Phases
    • Preclinical Studies
    • Phase 0 (Microdosing Studies)
    • Phase 1 (Safety and Dosage)
    • Phase 2 (Efficacy and Side Effects)
    • Phase 3 (Confirmation and Monitoring)
    • Phase 4 (Post-Marketing Surveillance)
  • Regulatory Guidelines
  • Clinical Trial Design and Protocol Development
  • Good Clinical Practice (GCP) and Compliance
  • U.S. FDA Regulations

Menu

Recent Posts

  • Real-World Data Integration in Phase 2 Study Planning
  • Role of Insurance Claims Data in Phase 4 Clinical Trials: Unlocking Real-World Insights
  • Cardiac Safety in Phase 1: QTc and Intensive ECG Monitoring
  • Communicating Phase 3 Results to Stakeholders: Strategies for Scientific, Regulatory, and Public Engagement
  • Platform and Basket Trials in Phase 2

Copyright © 2025 Clinical Research Made Simple.

Powered by PressBook WordPress theme